Glaukos Corporation
NYSE:GKOS
131.77 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 314.711 | 282.862 | 294.011 | 224.959 | 236.984 | 181.278 | 159.254 | 114.397 | 71.7 | 45.587 | 20.946 | 2.429 |
| Cost of Revenue
| 75.575 | 68.979 | 66.627 | 91.719 | 38.588 | 25.075 | 21.05 | 16.177 | 12.988 | 11.418 | 2.535 | 1.655 |
| Gross Profit
| 239.136 | 213.883 | 227.384 | 133.24 | 198.396 | 156.203 | 138.204 | 98.22 | 58.712 | 34.169 | 18.411 | 0.774 |
| Gross Profit Ratio
| 0.76 | 0.756 | 0.773 | 0.592 | 0.837 | 0.862 | 0.868 | 0.859 | 0.819 | 0.75 | 0.879 | 0.319 |
| Reseach & Development Expenses
| 143.768 | 123.271 | 110.999 | 85.392 | 72.053 | 49.676 | 44.225 | 29.223 | 25.047 | 19.205 | 15.511 | 13.299 |
| General & Administrative Expenses
| 220.668 | 190.425 | 178.057 | 169.801 | 174.135 | 119.529 | 96.26 | 64.756 | 43.961 | 27.735 | 16.598 | 8.973 |
| Selling & Marketing Expenses
| 3.4 | 2.5 | 1.2 | 1.6 | 2.5 | 1.8 | 2.1 | 1.6 | 0.8 | 0.4 | 0.5 | 0.6 |
| SG&A
| 224.068 | 192.925 | 179.257 | 171.401 | 176.635 | 119.529 | 96.26 | 64.756 | 43.961 | 28.135 | 17.098 | 9.573 |
| Other Expenses
| -0.558 | -4.771 | -4.311 | 2.975 | -0.348 | -1.618 | 0 | 0 | 0 | 28.135 | 17.098 | 0 |
| Operating Expenses
| 367.836 | 316.196 | 290.256 | 256.793 | 248.688 | 169.205 | 140.485 | 93.979 | 69.008 | 47.34 | 32.609 | 22.565 |
| Operating Income
| -128.7 | -102.313 | -62.872 | -123.553 | -50.292 | -13.002 | -2.281 | 4.241 | -10.296 | -13.171 | -14.198 | -22.098 |
| Operating Income Ratio
| -0.409 | -0.362 | -0.214 | -0.549 | -0.212 | -0.072 | -0.014 | 0.037 | -0.144 | -0.289 | -0.678 | -9.098 |
| Total Other Income Expenses Net
| -0.558 | 3.884 | 13.605 | -8.761 | 0.256 | -1.618 | -5.32 | 0.043 | -27.012 | 0.005 | 0.271 | 0.079 |
| Income Before Tax
| -133.727 | -98.429 | -49.267 | -132.314 | -50.036 | -12.368 | 0.001 | 4.565 | -38.288 | -14.039 | -14.221 | -22.019 |
| Income Before Tax Ratio
| -0.425 | -0.348 | -0.168 | -0.588 | -0.211 | -0.068 | 0 | 0.04 | -0.534 | -0.308 | -0.679 | -9.065 |
| Income Tax Expense
| 0.934 | 0.766 | 0.326 | -11.966 | -65.46 | 0.583 | 0.093 | 0.043 | 0.033 | 0.018 | 0.006 | 0.003 |
| Net Income
| -134.661 | -99.195 | -49.593 | -120.348 | 15.424 | -12.951 | -0.092 | 4.522 | -37.241 | -12.126 | -12.639 | -19.331 |
| Net Income Ratio
| -0.428 | -0.351 | -0.169 | -0.535 | 0.065 | -0.071 | -0.001 | 0.04 | -0.519 | -0.266 | -0.603 | -7.958 |
| EPS
| -2.78 | -2.09 | -1.07 | -2.7 | 0.41 | -0.37 | -0.003 | 0.14 | -2.13 | -0.49 | -0.51 | -9.73 |
| EPS Diluted
| -2.78 | -2.09 | -1.07 | -2.7 | 0.37 | -0.37 | -0.003 | 0.12 | -2.13 | -0.49 | -0.51 | -9.73 |
| EBITDA
| -82.116 | -104.709 | -65.895 | -118.199 | -47.471 | -13.002 | 0.045 | 5.13 | -10.214 | -8.937 | -13.028 | -21.46 |
| EBITDA Ratio
| -0.261 | -0.37 | -0.224 | -0.525 | -0.2 | -0.072 | 0 | 0.045 | -0.142 | -0.196 | -0.622 | -8.835 |